Personal Home Page

http://dbbs.wustl.edu/dbbs/website.nsf/fa/7fb570039c82425186257028002454b2?opendocument

Articles in Scholarly Journals [Incomplete List]

1. External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer
   Gynecologic Oncology, vol. 106, no. 1, pp. 215–220, 2007
2. Body mass index: Relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer
   Gynecologic Oncology, vol. 104, no. 3, pp. 535–539, 2007
3. Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma
   International Journal of Radiation OncologyBiologyPhysics, vol. 67, no. 2, pp. 480–484, 2007
4. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy
   Cancer, vol. 110, no. 6, pp. 1281–1286, 2007
5. Effect of a T0 radical hysterectomy specimen on survival for early stage cervical cancer?
   Gynecologic Oncology, vol. 107, no. 2, pp. 280–284, 2007
6. Profiling Microdissected Epithelium and Stroma to Model Genomic Signatures for Cervical Carcinogenesis Accommodating for Covariates
   Cancer Research, vol. 67, no. 15, pp. 7113–7123, 2007
7. Human papillomaviruses target the double-stranded RNA protein kinase pathway
   Journal of General Virology, vol. 87, no. 11, pp. 3183–3193, 2006
8. Gene expression patterns in advanced human cervical cancer
   International Journal of Gynecological Cancer, vol. 16, no. 2, pp. 562–567, 2006
9. MLH3 Mutation in Endometrial Cancer
   Cancer Research, vol. 66, no. 15, pp. 7502–7508, 2006
10. DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis
    Modern Pathology, vol. 19, no. 10, Article ID 3800654, 5 pages, 2006
11. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer
    Oncogene, vol. 25, no. 39, Article ID 1209530, 9 pages, 2006
12. Cervical Tissue Collection Methods for RNA Preservation: Comparison of Snap-frozen, Ethanol-fixed, and RNAlater-fixation
    Diagnostic Molecular Pathology, vol. 15, no. 3, pp. 144–148, 2006
13. Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma
    Cancer, vol. 107, no. 1, pp. 83–89, 2006
14. Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy
    Radiation Medicine, vol. 24, no. 9, pp. 625–630, 2006
15. Colposcopic accuracy of obstetrics and gynecology residents
    Gynecologic Oncology, vol. 103, no. 3, pp. 966–970, 2006
16. Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer
    Gynecologic Oncology, vol. 103, no. 2, pp. 489–493, 2006
17. Long-term outcome of women who undergo panniculectomy at the time of gynecologic surgery
    Gynecologic Oncology, vol. 102, no. 1, pp. 86–91, 2006
18. CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan
    Gynecologic Oncology, vol. 103, no. 1, pp. 212–218, 2006
19. Identification of chromosomal alterations important in the development of cervical intraepithelial neoplasia and invasive carcinoma using alignment of DNA microarray data
    Gynecologic Oncology, vol. 103, no. 2, pp. 458–462, 2006
20. Phase II evaluation of a 3-day infusion of topotecan in patients with recurrent ovarian or primary peritoneal cancer
    Gynecologic Oncology, vol. 103, no. 2, pp. 637–641, 2006
21. Cervical cancer prevention in the era of prophylactic vaccines: A preview for gynecologic oncologists?
    Gynecologic Oncology, vol. 102, no. 3, pp. 552–562, 2006
22. Human papillomavirus type and tobacco use as predictors of survival in early stage cervical carcinoma
    Gynecologic Oncology, vol. 98, no. 1, pp. 84–91, 2005
23. Resource utilization for ovarian cancer patients at the end of life: How much is too much?
    Gynecologic Oncology, vol. 99, no. 2, pp. 261–266, 2005
24. Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET
    International Journal of Radiation Oncology*Biology*Physics, vol. 61, no. 2, pp. 444–449, 2005
25. Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography
    Cancer, vol. 104, no. 11, pp. 2484–2491, 2005
26. Cervical sarcomas: An analysis of incidence and outcome
    Gynecologic Oncology, vol. 99, no. 2, pp. 348–351, 2005
27. IGSF4 promoter methylation and expression silencing in human cervical cancer
    Gynecologic Oncology, vol. 96, no. 1, pp. 150–158, 2005
28. FDG-PET evaluation of vaginal carcinoma
    International Journal of Radiation Oncology*Biology*Physics, vol. 62, no. 3, pp. 733–737, 2005
29. Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence
    International Journal of Radiation Oncology*Biology*Physics, vol. 61, no. 2, pp. 450–455, 2005
30. Fine mapping and evaluation of candidate genes for cervical cancer on 11q23
    Genes, Chromosomes and Cancer, vol. 43, no. 1, pp. 95–103, 2005
31. Phase I Study of Docetaxel in Combination with the P-Glycoprotein Inhibitor, Zosuquidar, in Resistant Malignancies
    Clinical Cancer Research, vol. 10, no. 21, pp. 7220–7228, 2004
32. Expression and Localization of GRP75 in Human Epithelial Tumors and Normal Tissues
    Applied Immunohistochemistry & Molecular Morphology, pp. 132–138, 2004
33. Increased Risk for Hereditary Nonpolyposis Colorectal Cancer-Associated Synchronous and Metachronous Malignancies in Patients with Microsatellite Instability-Positive Endometrial Carcinoma Lacking MLH1 Promoter Methylation
    Clinical Cancer Research, vol. 10, no. 2, pp. 481–490, 2004
34. Spindle Cell Ossifying Amyloidotic Tumor of the Fallopian Tube
    International Journal of Gynecological Pathology, vol. 23, no. 3, pp. 273–277, 2004
35. Synchronous ovarian metastases at the time of laparotomy for colon cancer
    The Women's Oncology Review, vol. 4, no. 2, pp. 107–108, 2004
36. Penetrance and Expressivity of MSH6 Germline Mutations in Seven Kindreds Not Ascertained by Family History
    The American Journal of Human Genetics, vol. 74, no. 6, pp. 1262–1269, 2004
37. Lymph node control in cervical cancer
    International Journal of Radiation Oncology*Biology*Physics, vol. 59, no. 3, pp. 706–712, 2004
38. Cervical carcinoma in the elderly
    Cancer, vol. 103, no. 1, pp. 85–91, 2004
39. Synchronous ovarian metastases at the time of laparotomy for colon cancer
    Gynecologic Oncology, vol. 92, no. 3, pp. 851–855, 2004
40. Panniculectomy: improving lymph node yield in morbidly obese patients with endometrial neoplasms
    Gynecologic Oncology, vol. 94, no. 2, pp. 436–441, 2004
41. Surgical?pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply?
    Gynecologic Oncology, vol. 94, no. 2, pp. 249–255, 2004
42. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Gynecologic Oncology, vol. 95, no. 1, pp. 70–76, 2004
43. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer
    Gynecologic Oncology, vol. 95, no. 3, pp. 546–551, 2004
44. Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies
    Cancer, vol. 98, no. 3, pp. 610–617, 2003
45. Liquid-based cytology for the postirradiation surveillance of women with gynecologic malignancies
    Gynecologic Oncology, vol. 91, no. 1, pp. 134–138, 2003
46. Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers
    Proceedings of the National Academy of Sciences, vol. 100, no. 10, pp. 5908–5913, 2003
47. Denaturing High-Performance Liquid Chromatography for Detecting and Typing Genital Human Papillomavirus
    Journal of Clinical Microbiology, vol. 41, no. 12, pp. 5563–5571, 2003
48. Acute abdominal pain with a calcified pelvic mass
    Journal of Pediatric and Adolescent Gynecology, vol. 16, no. 4, pp. 237–241, 2003
49. A relationship between methylenetetrahydrofolate reductase variants and the development of invasive cervical cancer
    Gynecologic Oncology, vol. 90, no. 3, pp. 560–565, 2003
50. Investigational New Drugs, vol. 21, no. 4, pp. 453–457, 2003
51. A phase II study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer
    Gynecologic Oncology, vol. 91, no. 2, pp. 318–325, 2003
52. Randomized Trial of Cisplatin and Ifosfamide With or Without Bleomycin in Squamous Carcinoma of the Cervix: A Gynecologic Oncology Group Study
    Journal of Clinical Oncology, vol. 20, no. 7, pp. 1832–1837, 2002
53. Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer
    Molecular Pathology, vol. 55, no. 3, pp. 153–155, 2002
54. Journal of Genetic Counseling, vol. 11, no. 2, pp. 81–96, 2002
55. Phase I study of rubitecan and gemcitabine in patients with advanced malignancies
    Annals of Oncology, vol. 13, no. 11, pp. 1819–1825, 2002
56. Phase II Trial of Pyrazoloacridine in Patients with Persistent or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study
    Gynecologic Oncology, vol. 84, no. 2, pp. 241–244, 2002
57. Epithelial ovarian tumors of low malignant potential: the role of microinvasion
    Obstetrics & Gynecology, vol. 99, no. 1, pp. 11–17, 2002
58. Utility and cost-effectiveness of preoperative autologous blood donation in gynecologic and gynecologic oncology patients
    Obstetrics & Gynecology, vol. 99, no. 5, pp. 771–776, 2002
59. Ribosomal DNA methylation in patients with endometrial carcinoma
    Cancer, vol. 94, no. 11, pp. 2941–2952, 2002
60. MSI in endometrial carcinoma: Absence of MLH1 promoter methylation is associated with increased familial risk for cancers
    International Journal of Cancer, vol. 99, no. 5, pp. 697–704, 2002
61. Use of Complementary and Alternative Medicine among Women with Gynecologic Cancers
    Gynecologic Oncology, vol. 84, no. 3, pp. 363–367, 2002
62. Prospective Evaluation of Positron Emission Tomography for the Detection of Groin Node Metastases from Vulvar Cancer
    Gynecologic Oncology, vol. 85, no. 1, pp. 179–184, 2002
63. Microsatellite Instability, MLH1 Promoter Methylation, and Loss of Mismatch Repair in Endometrial Cancer and Concomitant Atypical Hyperplasia
    Gynecologic Oncology, vol. 86, no. 1, pp. 62–68, 2002
64. The Significance of Pneumatosis Intestinalis or Bowel Perforation in Patients with Gynecologic Malignancies
    Gynecologic Oncology, vol. 86, no. 1, pp. 79–84, 2002
65. Factors Predicting Subcutaneous Implanted Central Venous Port Function: The Relationship between Catheter Tip Location and Port Failure in Patients with Gynecologic Malignancies
    Gynecologic Oncology, vol. 83, no. 3, pp. 533–536, 2001
66. Genotypic and phenotypic progression in endometrial tumorigenesis: Determining when defects in DNA mismatch repair andKRAS2 occur
    Genes, Chromosomes and Cancer, vol. 32, no. 4, pp. 295–301, 2001
67. No evidence forBCL10 mutation in endometrial cancers with microsatellite instability
    Human Mutation, vol. 17, no. 2, pp. 117–121, 2001
68. Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes
    International Journal of Radiation Oncology*Biology*Physics, vol. 49, no. 3, pp. 733–738, 2001
69. Loss of heterozygosity at 11q23.3 in vasculoinvasive and metastatic squamous cell carcinoma of the cervix
    Human Pathology, vol. 32, no. 5, pp. 475–478, 2001
70. Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFBR2) in sporadic ovarian cancer
    Molecular Pathology, vol. 54, no. 4, pp. 240–243, 2001
71. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
    Oncogene, vol. 20, no. 12, Article ID 1204175, 9 pages, 2001
72. ROLE OF THE ULTRASONIC SURGICAL ASPIRATOR IN GYNECOLOGY
    Obstetrics and Gynecology Clinics of North America, vol. 28, no. 4, pp. 775–790, 2001
73. Association between DQB1 and cervical cancer in patients with human papillomavirus and family controls
    Obstetrics & Gynecology, vol. 95, no. 1, pp. 134–140, 2000
74. Cervical cancer suppressor gene is within 1 cM on 6p23
    Genes, Chromosomes and Cancer, vol. 27, no. 4, pp. 373–379, 2000
75. Evaluation of Gemcitabine in Patients with Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology Group
    Gynecologic Oncology, vol. 76, no. 2, pp. 204–207, 2000
76. Current Opinion in Oncology, vol. 12, no. 5, pp. 508–513, 2000
77. Clinical significance of microsatellite instability in endometrial carcinoma
    Cancer, vol. 89, no. 8, pp. 1758–1764, 2000
78. Atypical Clustering of Gynecologic Malignancies: A Family Study Including Molecular Analysis of Candidate Genes
    Gynecologic Oncology, vol. 77, no. 1, pp. 18–25, 2000
79. Absence of PTEN Repeat Tract Mutation in Endometrial Cancers with Microsatellite Instability
    Gynecologic Oncology, vol. 79, no. 1, pp. 101–106, 2000
80. Radical hysterectomy for cervical cancer in obese women
    Obstetrics & Gynecology, vol. 96, no. 5, pp. 727–731, 2000
81. Mutational Analysis of the PMS2 Gene in Sporadic Endometrial Cancers with Microsatellite Instability
    Gynecologic Oncology, vol. 74, no. 3, pp. 395–399, 1999
82. Differences in patterns ofTP53 andKRAS2 mutations in a large series of endometrial carcinomas with or without microsatellite instability
    Cancer, vol. 85, no. 1, pp. 119–126, 1999
83. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix stage IB and IIA treated with preoperative irradiation and surgery
    International Journal of Radiation Oncology*Biology*Physics, vol. 45, no. 3, pp. 645–651, 1999
84. Analysis of MSH3 in endometrial cancers with defective DNA mismatch repair?
    Journal of the Society for Gynecologic Investigation, vol. 5, no. 4, pp. 210–216, 1998
85. Mapping an Endometrial Cancer Tumor Suppressor Gene at 10q25 and Development of a Bacterial Clone Contig for the Consensus Deletion Interval
    Genomics, vol. 52, no. 1, pp. 9–16, 1998
86. Cervial intraepithelial neoplasia III shows frequent allelic loss in 3p and 6p
    Genes, Chromosomes and Cancer, vol. 22, no. 1, pp. 57–65, 1998
87. Cancer among first-degree relatives of probands with invasive and borderline ovarian cancer*1
    Obstetrics & Gynecology, vol. 92, no. 4, pp. 589–595, 1998
88. Loss of heterozygosity in clinical stage IB cervical carcinoma: Relationship with clinical and histopathologic features*1
    Human Pathology, vol. 29, no. 4, pp. 364–370, 1998
89. Expression of ?v?3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas
    Human Pathology, vol. 28, no. 4, pp. 443–449, 1997
90. Mutational analysis ofMLH1 andMSH2 in 25 prospectively-acquired RER+ endometrial cancers
    Genes, Chromosomes and Cancer, vol. 18, no. 3, pp. 219–227, 1997
91. Topotecan in Platinum- and Paclitaxel-Resistant Ovarian Cancer
    Gynecologic Oncology, vol. 66, no. 3, pp. 480–486, 1997
92. Potential of Cervical Electrosurgical Excision Procedure for Diagnosis and Treatment of Cervical Intraepithelial Neoplasia
    Gynecologic Oncology, vol. 57, no. 3, pp. 286–293, 1995
93. Analysis of exposure times and dose escalation of paclitaxel in ovarian cancer cell lines
    Cancer, vol. 74, no. 7, pp. 1891–1898, 1994
94. In situ localization of parathyroid hormone-like protein and mRNA in intraepithelial neoplasia and invasive carcinoma of the uterine cervix
    Human Pathology, vol. 24, no. 10, pp. 1058–1066, 1993
95. A comparison of wound healing after epithelial resection by ultrasonic surgical aspiration and ablation by the carbon dioxide laser,
    Gynecologic Oncology, vol. 46, no. 3, pp. 351–356, 1992
96. HPV-16 viral transcripts in vulvar neoplasia: Preliminary studies
    Gynecologic Oncology, vol. 42, no. 3, pp. 250–255, 1991
97. Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential
    Gynecologic Oncology, vol. 42, no. 2, pp. 124–130, 1991
98. Radiation therapy in the treatment of cervical Cancer: The university of Chicago/Michael reese hospital experience
    Journal of Surgical Oncology, vol. 44, no. 3, pp. 157–165, 1990